ACTIVE

Syngenta Seeds

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result253,2 k €+6,5 %over 1 year

Revenue18,4 M €-2,2 %over 1 year

Equity946,5 k €-20,7 %over 1 year

Workforce21,3 ETP-8,2 %over 1 year

Identity

Source · BCE/KBO

Syngenta Seeds is a Public limited company incorporated in 1949. Its main activity is: Wholesale of grain, unmanufactured tobacco, seeds and animal feeds. Its registered office is in Gent. It employs on average 21,3 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0404.599.569
Incorporation: 26/04/1949
Legal form: Public limited company
Registered office: Technologiepark-Zwijnaarde 30
9052 Gent · FlandreSee on map
Contributed capital: 662 000,00 €
Latest accounts: 31/12/2025
Average workforce: 21,3 ETP

Activities (NACE)

46211Wholesale of grain, unmanufactured tobacco, seeds and animal feeds· main 46211Wholesale of grain, unmanufactured tobacco, seeds and animal feeds 46752Wholesale of chemical products 46852Wholesale trade, except of motor vehicles and motorcycles 51210Freight air transport

Joint committees (3)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 27 filings

Trend over 10 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	18,4 M €	-2.2%	18,9 M €	+3.6%	18,2 M €	+7.1%	17 M €	+6.9%	15,9 M €
EBITDA	355,6 k €	+59.8%	222,6 k €	-44.7%	402,1 k €	+73.6%	231,6 k €	+66.1%	139,4 k €
Operating result	352,3 k €	+59.6%	220,8 k €	-44.9%	400,4 k €	+90.3%	210,4 k €	-0.2%	211 k €
Net result	253,2 k €	+6.5%	237,8 k €	-20.7%	299,7 k €	+174%	109,5 k €	+2.8%	106,5 k €
Balance sheet
Equity	946,5 k €	-20.7%	1,2 M €	+24.9%	955,5 k €	-17.3%	1,2 M €	+10.5%	1 M €
Total assets	2,7 M €	-45.1%	4,9 M €	-9.8%	5,4 M €	-10.5%	6,1 M €	+51.7%	4 M €
Cash	43,1 k €		–		76 k €		–		0,4 €
Debts	1,7 M €	-53.0%	3,7 M €	-17.2%	4,5 M €	-8.9%	4,9 M €	+66.4%	3 M €
Other
Workforce	21,3 ETP	-8.2%	23,2 ETP	+0.4%	23,1 ETP	-1.7%	23,5 ETP	-1.7%	23,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 14 ended

Active mandates

Kurt Goethals

Director · since 12 mai 2025 · until 11 mai 2031

Active

Johan De Dobbelaere

Director · since 01 juin 2022 · until 01 juin 2028

Active

Richard Peletier

Director · since 26 mai 2020 · until 30 juin 2026

Active

Kurt Lefebvre

Director · since 01 mars 2020 · until 01 mars 2025

Active

Ended mandates

Johan De Dobbelaere

Director · since 01 juin 2022

Ended

Kurt Lefebvre

Director · since 01 mars 2020 · until 01 mars 2026

Ended

Erik van 't Hof

Director · since 01 novembre 2017 · until 25 mai 2020

Ended

Jonathan Halstead

Director · since 01 novembre 2017 · until 01 mars 2020

Ended

Other companies at this address

Technologiepark-Zwijnaarde 30 9052 Gent

Company	CBE no.
Confo Therapeutics● Active	0632.474.939
DEVGEN● Active	0461.432.562
Eastman Chemical Technology● Active	0671.793.393

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	20/07/2026	11/07/2025	02/12/2024	24/10/2023	02/12/2024	11/08/2022
General meeting	30/06/2026	24/06/2025	25/06/2024	27/06/2023	30/06/2022	29/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 27 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	30/06/2026	20/07/2026	Dutch	PDF
Full model	31/12/2024	24/06/2025	11/07/2025	Dutch	PDF
Full modelCorrection	31/12/2023	25/06/2024	02/12/2024	Dutch	PDF
Full model	31/12/2023	25/06/2024	09/07/2024	Dutch	PDF
Full model	31/12/2022	27/06/2023	24/10/2023	Dutch	PDF
Full modelCorrection	31/12/2021	30/06/2022	02/12/2024	Dutch	PDF
Full modelCorrection	31/12/2021	29/06/2022	09/07/2024	Dutch	PDF
Full model	31/12/2021	29/06/2022	24/07/2023	Dutch	PDF
Full model	31/12/2020	29/06/2021	11/08/2022	Dutch	PDF
Full model	31/12/2019	30/06/2020	29/08/2020	Dutch	PDF
Full modelCorrection	31/12/2018	25/06/2019	09/06/2020	Dutch	PDF
Full modelCorrection	31/12/2018	25/06/2019	12/01/2020	Dutch	PDF
Full model	31/12/2018	25/06/2019	18/08/2019	Dutch	PDF
Full model	31/12/2017	26/06/2018	01/08/2018	Dutch	PDF
Full model	31/12/2016	27/06/2017	31/08/2017	Dutch	PDF
Full model	31/12/2015	28/06/2016	10/07/2016	Dutch	PDF
Full modelCorrection	31/12/2014	29/06/2015	13/07/2015	Dutch	PDF
Full model	31/12/2014	29/06/2015	30/06/2015	Dutch	PDF
Full model	31/12/2013	30/06/2014	14/07/2014	Dutch	PDF
Full model	31/12/2012	28/06/2013	11/07/2013	Dutch	PDF
Full model	31/12/2011	08/01/2013	20/02/2013	Dutch	PDF
Full model	31/12/2010	01/08/2012	20/02/2013	Dutch	PDF
Full model	31/12/2009	22/11/2010	29/11/2010	Dutch	PDF
Full model	31/12/2008	10/09/2009	22/09/2009	Dutch	PDF

View all 27 filings

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 14 ended

Active mandates

Kurt Goethals

Director · since 12 mai 2025 · until 11 mai 2031

Active

Johan De Dobbelaere

Director · since 01 juin 2022 · until 01 juin 2028

Active

Richard Peletier

Director · since 26 mai 2020 · until 30 juin 2026

Active

Kurt Lefebvre

Director · since 01 mars 2020 · until 01 mars 2025

Active

Ended mandates

Johan De Dobbelaere

Director · since 01 juin 2022

Ended

Kurt Lefebvre

Director · since 01 mars 2020 · until 01 mars 2026

Ended

Erik van 't Hof

Director · since 01 novembre 2017 · until 25 mai 2020

Ended

Jonathan Halstead

Director · since 01 novembre 2017 · until 01 mars 2020

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates13/07/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/03/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other18/09/2024
DIVERSEN
PDF
Other16/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DIVERSEN
PDF
Mandates04/09/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/07/2022
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 2025253,2 k €↑
2024
Annual accounts 2024237,8 k €↓
2023
Annual accounts 2023299,7 k €↑
2022
Annual accounts 2022109,5 k €↑
2021
Annual accounts 2021106,5 k €↓
2020
Annual accounts 2020183,8 k €↓
2015
Annual accounts 2015428 k €↑
2014
Annual accounts 2014284,2 k €↓
2013
Annual accounts 2013336 k €↑
2012
Annual accounts 2012222 k €
26/04/1949
IncorporationPublic limited company

Syngenta Seeds

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline